These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4318777)

  • 21. H-2 antigen requirements in the in vitro induction of SV40-specific cytotoxic T lymphocytes.
    Gooding LR; Edwards CB
    J Immunol; 1980 Mar; 124(3):1258-62. PubMed ID: 6244348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of a complex of SV40 large tumor antigen and 53K cellular protein on the surface of SV40-transformed mouse cells.
    Santos M; Butel JS
    J Cell Biochem; 1982; 19(2):127-44. PubMed ID: 6294133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rat T lymphocyte-specific antigens and their cross-reactivity with mouse T cells.
    Ishii Y; Koshiba H; Yamaoka H; Kikuchi K
    J Immunol; 1976 Aug; 117(2):497-503. PubMed ID: 1084900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro studies on the cellular immune response of tumor-bearing mice to SV40-transformed cells.
    Blasecki JW; Tevethia SS
    J Immunol; 1975 Jan; 114(1 Pt 1):244-9. PubMed ID: 163278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A SPECIFIC COMPLEMENT-FIXING ANTIGEN PRESENT IN SV40 TUMOR AND TRANSFORMED CELLS.
    BLACK PH; ROWE WP; TURNER HC; HUEBNER RJ
    Proc Natl Acad Sci U S A; 1963 Dec; 50(6):1148-56. PubMed ID: 14096190
    [No Abstract]   [Full Text] [Related]  

  • 26. Surface antigens on hamster cells transformed by SV40, BK virus and JC virus.
    Nozawa A; Kato K; Uchida S
    Jpn J Exp Med; 1987 Oct; 57(5):267-75. PubMed ID: 2453689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro immunization against tumour-associated antigen of methylcholanthrene-induced sarcoma.
    Indrová M; Bubeník J
    Folia Biol (Praha); 1978; 24(2):118-27. PubMed ID: 658547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of human papovavirus T antigens.
    Dougherty RM
    J Gen Virol; 1976 Oct; 33(1):61-70. PubMed ID: 62024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cross-reacting antigens of the mammalian ovular zona pellucida].
    Verbitskiĭ MSh; Papazov IP; Shoshev VN; Mikhaĭlov AT; Babaev VR
    Ontogenez; 1980; 11(6):583-93. PubMed ID: 6777722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
    Fidler IJ; Kataoka T; Hanna MG
    Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro selection of SV40 T antigen epitope loss variants by site-specific cytotoxic T lymphocyte clones.
    Tanaka Y; Tevethia SS
    J Immunol; 1988 Jun; 140(12):4348-54. PubMed ID: 2453578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Differences in the fixation of antibodies in presence or absence of complement on SV40 transformed cells (author's transl)].
    Duthu A; de Vaux Saint Cyr C
    Bull Cancer; 1979; 66(1):17-24. PubMed ID: 217471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity of guinea pig cells transformed in culture by chemical carcinogens.
    Ohanian SH; McCabe RP; Evans CH
    J Natl Cancer Inst; 1981 Dec; 67(6):1363-8. PubMed ID: 6273639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigenicity of clones of mouse prostate cells transformed in vitro.
    Embleton MJ; Heidelberger C
    Int J Cancer; 1972 Jan; 9(1):8-18. PubMed ID: 4552543
    [No Abstract]   [Full Text] [Related]  

  • 35. Antigenic differences between spleen-seeking and lymph node-seeking thymus cells.
    Schlesinger M; Shlomai-Korzash Z; Israèl E
    Eur J Immunol; 1973 Jun; 3(6):335-9. PubMed ID: 4543317
    [No Abstract]   [Full Text] [Related]  

  • 36. [Induction of the "tumor" (T) antigen of SV40 virus in various tissue cultures].
    Al'tshteĭn AD; Sarycheva OF
    Vopr Virusol; 1970; 15(1):78-84. PubMed ID: 4316400
    [No Abstract]   [Full Text] [Related]  

  • 37. Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells.
    Paciucci PA; Macphail S; Bach FH; Zarling JM
    J Immunol; 1980 Jul; 125(1):36-9. PubMed ID: 6155401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy of SV40 induced tumours in mice: a model for vaccine development.
    Bright RK; Shearer MH; Pass HI; Kennedy RC
    Dev Biol Stand; 1998; 94():341-53. PubMed ID: 9776255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of immunorecessive cytotoxic T lymphocyte determinant V on SV40 T antigen following cocultivation with site-specific cytotoxic T lymphocyte clone Y-5.
    Tanaka Y; Tevethia SS
    Intervirology; 1990; 31(2-4):197-202. PubMed ID: 1695620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non T suppressor cells in the lymph nodes of mice bearing methylcholanthrene-induced sarcomas.
    Indrová M; Bubeník J
    Folia Biol (Praha); 1981; 27(3):217-22. PubMed ID: 6455309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.